Categories: Business News

BIO CEO says more consistency needed in FDA review process

By Deena Beasley SAN DIEGO, June 23 (Reuters) – U.S. biotechnology industry trade group BIO worked with the Food and Drug Administration on plans announced on Monday to…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: June 24, 2026 02:05:08 IST

By Deena Beasley SAN DIEGO, June 23 (Reuters) – U.S. biotechnology industry trade group BIO worked with the Food and Drug Administration on plans announced on Monday to speed clinical trials and

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: June 24, 2026 02:05:08 IST

Recent Posts

Taylor Swift lands top trophy at MTV's Video Music Awards

By Lisa Richwine LOS ANGELES, Sept 27 (Reuters) - Taylor Swift won the most coveted…

September 28, 2026

India's TakeMe2Space to launch orbital computing satellite on SpaceX rocket

By Akash Sriram BENGALURU, Sept 28 (Reuters) - Indian space startup TakeMe2Space plans to launch…

September 28, 2026

Australia's Northern Star rejects $27 billion takeover approach from Gold Fields

By Melanie Burton and Roshan Thomas MELBOURNE, Sept 28 (Reuters) - Australia's top gold producer…

September 28, 2026